Trials / Completed
CompletedNCT02836366
Targon PH+ Follow-Up
Prospective Cohort Study of Proximal Humeral Fractures Treated With Targon® PH+
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (actual)
- Sponsor
- Aesculap AG · Industry
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Not accepted
Summary
With this study results of the Targon® PH+ nail, developed for the treatment of humeral head fractures, will be investigated clinically, radiological evaluation is optional. The primary objective of this study is to examine the effect of a plating treatment on the speed of recovery of functional capacity in adult patients. Secondary aims are to examine the level of pain, patient satisfaction, shoulder function, quality of life, radiological evaluation and complications. Targon PH+ is CE certified. The study is a non-interventional cohort study sponsored by Aesculap
Conditions
Timeline
- Start date
- 2016-03-01
- Primary completion
- 2019-04-01
- Completion
- 2019-04-01
- First posted
- 2016-07-19
- Last updated
- 2019-06-07
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02836366. Inclusion in this directory is not an endorsement.